on ABIVAX (EPA:ABVX)
ABIVAX: Details on Capital and Voting Rights as of July 31, 2026
On August 12, 2026, ABIVAX, listed on Euronext Paris, released information regarding its share capital. The share capital consists of 87,253,797 shares. As of the same date, the total number of theoretical and exercisable voting rights was 88,512,554.
Theoretical voting rights include all shares, even those without voting rights, while exercisable voting rights exclude the latter. This distinction allows for a better understanding of obligations regarding threshold crossings and compliance with the recommendations of the French Financial Markets Authority (AMF).
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ABIVAX news